HomeInsightsPE

Syncom Formulations (india) Ltd PE Ratio

Syncom Formulations (india) Ltd PE Ratio

stocks purchased

₹ 1.6 Cr

Volume transacted

stocks purchased

739.5 K

stocks traded

Last Updated time: 11 Oct 15:30 PM

Image

Syncom Formulations (India) Ltd

NSE: SYNCOMFORMUL

PE

73.5

Last updated: 11 Oct 15:30 PM

Key Highlights

  • The P/E Ratio of Syncom Formulations (India) Ltd is 73.5 as of 11 Oct 15:30 PM.
  • The P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 41.4 on March 2024 . This represents a CAGR of -3.59% over 3 years. .
  • The Latest Trading Price of Syncom Formulations (India) Ltd is ₹ 21.63 as of 11 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Syncom Formulations (India) Ltd

No data available

Company Fundamentals for Syncom Formulations (India) Ltd

No data available

Image

Syncom Formulations (India) Ltd

NSE: SYNCOMFORMUL

PRICE

21.63

-0.41 (-1.86%)

stock direction

Last updated: 11 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Syncom Formulations (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 202422.04
09 Oct 202421.84
08 Oct 202421.52
07 Oct 202419.57
04 Oct 202420.86
03 Oct 202421.32
01 Oct 202422.42
30 Sep 202421.81
27 Sep 202421.98
26 Sep 202421.32

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Syncom Formulations (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Syncom Formulations (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Syncom Formulations (India) Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Revenue of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Dividend Payout of Syncom Formulations (India) Ltd

No data available

* All values are in %

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 202417:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 202410:30

News

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total e...

Read more

13 Aug 202413:37

News

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

06 Aug 202411:37

News

Syncom Formulations (India) to discuss results

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

09 May 202413:44

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

07 Feb 202414:04

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Syncom Formulations (India) Ltd

What is the current PE Ratio of Syncom Formulations (India) Ltd?

The Current PE Ratio of Syncom Formulations (India) Ltd is 73.47 as on 11 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Oct 2024.

What was the PE Ratio of Syncom Formulations (India) Ltd last year?

The PE Ratio of Syncom Formulations (India) Ltd was 28.1 last year, now the PE ratio is 73.47, showing a year-on-year growth of 161.5%.

What does the PE Ratio of Syncom Formulations (India) Ltd indicate about its stock?

The PE Ratio of Syncom Formulations (India) Ltd is 73.47. This ratio indicates that investors are willing to pay 73.47 times the earnings per share for each share of Syncom Formulations (India) Ltd.

What is the PE Ratio Growth of Syncom Formulations (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Syncom Formulations (India) Ltd grew by 161.5% whereas, the EPS ratio grew by 10.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*